Comments on: Comments and Suggestions Regarding Hemispherx's Conference

By: Vish

Vish — Sat, 16 May 2009 16:07:24 +0000

It seems they have carefully planned these activities recently happening and statements like,”HEB can manage production” starting with a fractional part of their 45000sqft facility that has been inspected by FDA with minimal small infractions. Not to impede.” can really make stock run next week.

Let us see.

By: Satish

Satish — Fri, 15 May 2009 20:01:47 +0000

Hi,

I would like to know from the CEO if the Animal Toxicity studies are submitted to FDA or not and if these studies are required for approval. This will clear all the confusions, PERIOD!

Thanks.

By: Ian

Ian — Thu, 14 May 2009 05:04:34 +0000

The contact doesnt work… i am a math minor, and the sum thing doesnt work.

By: Ian

Ian — Thu, 14 May 2009 05:02:38 +0000

Message for CEO of HEB, ask what crucial paperwork was needed when they had to hold off on the submission. If the drug has been around 20 years like ive been reading, what other paperwork would have been needed? and the other, If the FDA approves ampligen, would that mean they recognize CFS for the first time, would that potentially be one reason they wouldn’t approve this drug? Are there any talks right now about with manufacturer that can produce the drug in mass quantities if it is approved.

By: Poppa

Poppa — Thu, 14 May 2009 02:26:50 +0000

Thanks Michael, for stepping up and asking those “tough” questions for the rest of us. Hopefully they will give some honest answers to your / our questions about the timing of all of this.